Research Article
Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
Table 1
Annual dispensing number and cost of Dupilumab in moderate-to-severe atopic dermatitis in the period January 2019 and December 2021.
| Gender | 2019 | 2020 | 2021 | Annual expenditure | Drug dispensing number | Annual expenditure | Drug dispensing number | Annual expenditure | Drug dispensing number |
| Females | 9.151,99 € | 20 | 117.134,45 € | 256 | 119.687,75 € | 288 | Males | 15.558,38 € | 34 | 141.841,73 € | 310 | 186.374,34 € | 450 | Total | 24.710,37 € | 54 | 258.976,2 € | 566 | 306.062,09 € | 738 |
|
|